These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22089789)

  • 21. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
    Dattwyler RJ; Luft BJ; Kunkel MJ; Finkel MF; Wormser GP; Rush TJ; Grunwaldt E; Agger WA; Franklin M; Oswald D; Cockey L; Maladorno D
    N Engl J Med; 1997 Jul; 337(5):289-94. PubMed ID: 9233865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
    Murata S; Aomatsu T; Yoden A; Tamai H
    Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
    Zinberg J; Chernaik R; Coman E; Rosenblatt R; Brandt LJ
    Am J Gastroenterol; 1991 Sep; 86(9):1251-4. PubMed ID: 1882806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Pediatric ceftriaxone nephrolithiasis.
    Avci Z; Karadag A; Odemis E; Catal F
    J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
    [No Abstract]   [Full Text] [Related]  

  • 29. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams.
    Dajani AS; Pokowski LH
    Scand J Infect Dis Suppl; 1990; 73():31-42. PubMed ID: 2091255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children.
    Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y
    J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection.
    Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M
    Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperuricosuria and urolithiasis].
    Koide T
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.
    Otunctemur A; Ozbek E; Polat EC; Cekmen M; Dursun M; Cakir SS
    Urolithiasis; 2014 Apr; 42(2):105-8. PubMed ID: 24310104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urate nephrolithiasis. Cause of consequence?].
    Mertz DP
    Fortschr Med; 1976 Jul; 94(20-21):1160-4. PubMed ID: 955552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone-associated biliary pseudolithiasis.
    Rienstra M; Bonten MJ; Gaillard CA
    Neth J Med; 2009 Mar; 67(3):113-4. PubMed ID: 19307687
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure and elemental composition of Ceftriaxone induced pediatric nephrolithiasis.
    Du Y; Kang M; Mena J; Stoller ML; Ho SP; Li J
    Urolithiasis; 2021 Aug; 49(4):309-320. PubMed ID: 33587147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection.
    Roncon-Albuquerque R; Pires I; Martins R; Real R; Sousa G; von Hafe P
    Neth J Med; 2009 Feb; 67(2):72-5. PubMed ID: 19299850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gallstones in association with the use of ceftriaxone in children].
    Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
    An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.